NSW (9739) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Nov, 2025Executive summary
Net sales for the six months ended September 30, 2025, increased 2.7% year-over-year to ¥24,854 million, while operating profit declined 14.4% to ¥2,360 million and profit attributable to owners of parent fell 12.6% to ¥1,666 million.
Comprehensive income decreased 12.5% year-over-year to ¥1,658 million.
Financial highlights
Gross profit rose to ¥5,039 million from ¥4,863 million year-over-year, but selling, general and administrative expenses increased significantly, impacting operating profit.
Basic earnings per share for the period was ¥111.83, down from ¥127.88 in the prior year.
Total assets as of September 30, 2025, were ¥47,318 million, with net assets at ¥36,402 million and an equity-to-asset ratio of 76.9%.
Cash and deposits at period end were ¥18,464 million, down from ¥19,666 million at the previous fiscal year-end.
Net cash provided by operating activities was ¥820 million, while investing activities used ¥1,337 million and financing activities used ¥674 million.
Outlook and guidance
Full-year forecast for fiscal year ending March 31, 2026: net sales of ¥51,000 million (up 1.9% year-over-year), operating profit of ¥5,100 million (down 16.6%), and profit attributable to owners of parent of ¥3,540 million (down 16.7%).
Basic earnings per share for the full year is projected at ¥237.59.
Latest events from NSW
- Sales grew, but profits fell on higher costs and one-time losses; lower profit forecast ahead.9739
Q3 20269 Feb 2026 - Quarterly profits and comprehensive income rose, with moderate growth forecast for the full year.9739
Q1 20258 Sep 2025 - Sales and profit rose modestly, with strong capital and higher cash reserves.9739
Q2 20258 Sep 2025 - Sales and profits rose, with strong capital and cash; full-year profit to dip slightly.9739
Q3 20258 Sep 2025 - Profit fell despite stable sales, with lower EPS and a cautious outlook for next year.9739
Q4 20258 Sep 2025 - Sales rose 4.2% year-over-year, but profits and net income declined; outlook remains cautious.9739
Q1 20268 Sep 2025